BioCentury | Nov 17, 2018
Emerging Company Profile
Sepset’s sepsis signature
...that Sepset's signature does not overlap with the Immunexpress gene set based on patent analysis. Inflammatix Inc....
...first presentation in the ER, or later when a patient reaches the ICU. Hancock said Inflammatix's...
...CEO: Jonathon Jafari Patents: None issued Companies and Institutions Mentioned Immunexpress Pty. Ltd., Brisbane, Australia Inflammatix Inc....
...first presentation in the ER, or later when a patient reaches the ICU. Hancock said Inflammatix's...
...CEO: Jonathon Jafari Patents: None issued Companies and Institutions Mentioned Immunexpress Pty. Ltd., Brisbane, Australia Inflammatix Inc....